SynthesisBMJ open2022

ALK inhibitors in ALK-rearranged non-small cell lung cancer with and without brain metastases: systematic review and network meta-analysis.

Jun Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.